Evidence map›Paper›PMID 34963199›Full record

ArticleACR open rheumatology2022

Caspase-8 Variant G Regulates Rheumatoid Arthritis Fibroblast-Like Synoviocyte Aggressive Behavior.

Cecilia Ansalone, Richard I Ainsworth, Gyrid Nygaard, Rizi Ai, Edward B Prideaux, Deepa Hammaker, Narayanan B Perumal, Ken Weichert, Frances Tung, Lalitha Kodandapani and 6 more

Open access · goldAbstract read
In one paragraph

Article in ACR open rheumatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Cecilia AnsaloneUniversity of California San Diego, La Jolla, California.ORCID https://orcid.org/0000-0001-8683-1718
Richard I AinsworthUniversity of California San Diego, La Jolla, California.
Gyrid NygaardUniversity of California San Diego, La Jolla, California.
Rizi AiUniversity of California San Diego, La Jolla, California.
Edward B PrideauxUniversity of California San Diego, La Jolla, California.
Deepa HammakerUniversity of California San Diego, La Jolla, California.ORCID https://orcid.org/0000-0001-5435-9498
Narayanan B PerumalLilly Biotechnology Center, San Diego, California.
Ken WeichertLilly Biotechnology Center, San Diego, California.
Frances TungLilly Biotechnology Center, San Diego, California.
Lalitha KodandapaniLilly Biotechnology Center, San Diego, California.
J Michael SauderLilly Biotechnology Center, San Diego, California.
Elisabeth C MertschingLilly Biotechnology Center, San Diego, California.
Robert J BenschopEli Lilly and Company, Indianapolis, Indiana.
David L BoyleUniversity of California San Diego, La Jolla, California.
Wei WangUniversity of California San Diego, La Jolla, California.
Gary S FiresteinUniversity of California San Diego, La Jolla, California.ORCID https://orcid.org/0000-0003-3495-960X
University of California San Diego · USUnity Biotechnology (United States) · USEli Lilly (United States) · US

Funding

Identification of key regulators in rheumatoid arthritisR01AR065466 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, WANG, WEI · 2014 to 2024
$4.6M
NIAMS NIH HHS R01 AR065466
6 · The paper itself

Abstract

objectiveFibroblast-like synoviocytes (FLS) play a pivotal role in rheumatoid arthritis (RA) by contributing to synovial inflammation and progressive joint damage. An imprinted epigenetic state is associated with the FLS aggressive phenotype. We identified CASP8 (encoding for caspase-8) as a differentially marked gene and evaluated its pathogenic role in RA FLSs.

methodsRA FLS lines were obtained from synovial tissues at arthroplasty and used at passage 5-8. Caspase-8 was silenced using small interfering RNA, and its effect was determined in cell adhesion, migration and invasion assays. Quantitative reverse transcription PCR and western blot were used to assess gene and protein expression, respectively. A caspase-8 selective inhibitor was used determine the role of enzymatic activity on FLS migration and invasion. Caspase-8 isoform transcripts and epigenetic marks in FLSs were analyzed in FLS public databases. Crystal structures of caspase-8B and G were determined.

resultsCaspase-8 deficiency in RA FLSs reduced cell adhesion, migration, and invasion independent of its catalytic activity. Epigenetic and transcriptomic analyses of RA FLSs revealed that a specific caspase-8 isoform, variant G, is the dominant isoform expressed (~80% of total caspase-8) and induced by PDGF. The crystal structures of caspase-8 variant G and B were identical except for a unique unstructured 59 amino acid N-terminal domain in variant G. Selective knockdown of caspase-8G was solely responsible for the effects of caspase-8 on calpain activity and cell invasion in FLS.

conclusionBlocking caspase-8 variant G could decrease cell invasion in diseases like RA without the potential deleterious effects of nonspecific caspase-8 inhibition.

Identifiers

PMID34963199
PMCPMC8992463
OpenAlexW4200587575

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.